Dr. Catherine Shu, MD
Claim this profileColumbia University
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
7 reported clinical trials
12 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
EGFR positive
Stage IV
Stage III
2Lung Cancer
Stage IV
EGFR positive
Stage III
Affiliated Hospitals
Clinical Trials Catherine Shu, MD is currently running
Spartalizumab Safety
for Cancer
This trial aims to ensure that spartalizumab remains safe and tolerable for patients who are already using it. The medication helps the immune system fight cancer, and the study ensures patients can keep accessing it safely.
Recruiting1 award Phase 11 criteria
Rituximab or Tocilizumab
for Immune-Related Side Effects
The purpose of this study is to examine how effective rituximab or tocilizumab are in treating side effects for people who are receiving immunotherapy treatment requiring prolonged steroid use. Immune-related side effects are caused by the activation of the immune system. Because rituximab and tocilizumab have been shown to effectively in treating other diseased that involve immune system activation, this study seeks to evaluate how effective they will be in treating immune-related side effects in people receiving immunotherapy treatment for cancer.
Recruiting1 award Phase 211 criteria
More about Catherine Shu, MD
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Catherine Shu, MD has experience with
- Durvalumab
- Tremelimumab
- Osimertinib
- Ramucirumab
- Rituximab
- Tocilizumab
Breakdown of trials Catherine Shu, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Epidermal Growth Factor Receptor Mutations
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Catherine Shu, MD specialize in?
Catherine Shu, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved EGFR positive patients, or patients who are Stage IV.
Is Catherine Shu, MD currently recruiting for clinical trials?
Yes, Catherine Shu, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Catherine Shu, MD has studied deeply?
Yes, Catherine Shu, MD has studied treatments such as Durvalumab, Tremelimumab, Osimertinib.
What is the best way to schedule an appointment with Catherine Shu, MD?
Apply for one of the trials that Catherine Shu, MD is conducting.
What is the office address of Catherine Shu, MD?
The office of Catherine Shu, MD is located at: Columbia University, New York, New York 10032 United States. This is the address for their practice at the Columbia University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.